Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecentriq
Tecentriq
Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer
Thu, 05/10/18 - 09:52 am
Roche
Exelixis
Tecentriq
Cotellic
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Mon, 05/7/18 - 09:50 am
Roche
Tecentriq
FDA
Genentech
lung cancer
Roche halts enrollment in a PhII combo study of Tecentriq and Cotellic in wake of several patient deaths
Endpoints
Wed, 04/11/18 - 11:02 am
Roche
Tecentriq
clinical trials
colon cancer
Exelixis
Cotellic
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Mon, 03/26/18 - 10:37 pm
Roche
Avastin
Tecentriq
lung cancer
Roche's Tecentriq cocktail notches another lung cancer success
Yahoo/Reuters
Mon, 03/26/18 - 09:38 am
Roche
Tecentriq
lung cancer
clinical trials
Roche's Tecentriq triumphs in squamous lung cancer. Can it make its mark against Merck?
Fierce Pharma
Tue, 03/20/18 - 03:27 pm
Roche
Tecentriq
squamous non-small cell lung cancer
Merck
Keytruda
In wake of Tecentriq bladder cancer bust and lost market share, Roche tries Tesaro combo
Fierce Pharma
Tue, 02/27/18 - 06:45 pm
Roche
Tecentriq
bladder cancer
Zejula
PARP inhibitors
Roche hails another PhIII win on Tecentriq combo, reports promising kidney cancer data
Endpoints
Mon, 02/5/18 - 07:07 pm
Roche
Tecentriq
kidney cancer
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
Fierce Pharma
Sat, 12/9/17 - 02:22 pm
Roche
Tecentriq
lung cancer
Roche's Tecentriq combo cuts risk of lung cancer progression
BioPharma Dive
Thu, 12/7/17 - 11:44 pm
Roche
Tecentriq
lung cancer
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Mon, 11/20/17 - 09:40 am
Roche
lung cancer
Genentech
Tecentriq
Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire
Fierce Pharma
Sat, 10/7/17 - 11:04 am
Roche
Tecentriq
bladder cancer
Keytruda
Merck
Most new cancer meds haven't proved they can improve or extend lives: study
Fierce Pharma
Thu, 10/5/17 - 09:38 am
cancer
oncology
Merck
Keytruda
Roche
Tecentriq
FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths
Endpoints
Sat, 09/16/17 - 12:06 pm
FDA
Roche
Keytruda
Tecentriq
clinical trials
FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports
Fierce Pharma
Tue, 09/12/17 - 10:00 pm
FDA
Tecentriq
Roche
bladder cancer
clinical trials
ASCO17: Merck touts Keytruda bladder benefit post Tecentriq failure
BioPharma Dive
Mon, 06/5/17 - 12:13 pm
Merck
Keytruda
bladder cancer
Tecentriq
ASCO 2017
Merck’s checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
Endpoints
Fri, 05/19/17 - 10:12 am
Merck
Keytruda
FDA
Roche
Tecentriq
In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study
Endpoints
Wed, 05/10/17 - 10:13 am
Roche
Tecentriq
clinical trials
bladder cancer
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Pfizer
Merck KGaA
AstraZeneca
Bavencio
avelumab
bladder cancer
Imfinzi
FDA
Opdivo
Tecentriq
Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer
Fierce Pharma
Tue, 04/18/17 - 09:00 pm
Roche
Tecentriq
bladder cancer
FDA
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »